General Information of Drug (ID: DM35V46)

Drug Name
NSC-677939
Synonyms
NSC-677939; NSC677939; CHEMBL1287982; AC1L8RA1; Diindolo[2,2-h]quinolizine; CTK8D1116; ZINC1647054; BDBM50332189; {Diindolo[2,3-a:3,2-h]quinolizine}; NCI60_027847; 14H-Diindolo[2,3-a:3,2-h]quinolizine; 14h-diindolo[2,3-a:3',2'-h]quinolizine
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 307.3
Logarithm of the Partition Coefficient (xlogp) 5.3
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C21H13N3
IUPAC Name
3,13,23-triazahexacyclo[11.11.0.02,10.04,9.016,24.017,22]tetracosa-1,3,5,7,9,11,14,16(24),17,19,21-undecaene
Canonical SMILES
C1=CC=C2C(=C1)C3=C(N2)C4=C5C(=C6C=CC=CC6=N5)C=CN4C=C3
InChI
InChI=1S/C21H13N3/c1-3-7-17-13(5-1)15-9-11-24-12-10-16-14-6-2-4-8-18(14)23-20(16)21(24)19(15)22-17/h1-12,22H
InChIKey
MNJDUMFRXPRNJB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
386223
TTD ID
D02DOX

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Quinone reductase 2 (NQO2) TTJLP0R NQO2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.